What is Medikabazaar?
Medikabazaar operates as India's largest online marketplace dedicated to medical products and supplies. Beyond mere product procurement, the company provides a comprehensive suite of services tailored for hospitals and medical establishments. It aims to be a one-stop destination, assisting clients in selecting appropriate medical products, ensuring efficient and timely delivery, and offering post-sales support to facilitate immediate product utilization. Medikabazaar leverages extensive experience in medical product consultation and supply chain management, catering to a wide array of healthcare facilities across India and beyond. The company is owned and operated by Boston Ivy Healthcare Solutions Pvt. Ltd., based in Mumbai.
How much funding has Medikabazaar raised?
Medikabazaar has raised a total of $445M across 4 funding rounds:
Series A
$5M
Series B
$300M
Series C
$75M
Other Financing Round
$65M
Series A (2018): $5M with participation from HealthQuad and KOIS
Series B (2020): $300M led by Ackermans & Van Haaren
Series C (2021): $75M supported by CDC Group, Sumitomo Mitsui Financial Group, KOIS, and Ackermans & Van Haaren
Other Financing Round (2022): $65M featuring HealthQuad, Creaegis, British International Investment, Lighthouse India Fund, KOIS Holdings, and Ackermans & Van Haaren
Key Investors in Medikabazaar
Ackermans & Van Haaren
Ackermans & Van Haaren, established in 1876 and headquartered in Belgium, is a holding company with diverse interests including Growth Capital, Marine Engineering & Contracting, Private Banking, Real Estate & Senior Care, and Energy & Resources. Their participation suggests a strategic interest in Medikabazaar's growth potential within the healthcare sector.
CDC Group
CDC Group, founded in 1948 in London, is a financial institution focused on investing in businesses across Africa and South Asia to foster growth and job creation. Their involvement highlights Medikabazaar's role in developing the South Asian healthcare market.
KOIS
KOIS Invest is a private equity investor specializing in blended finance for sustainable solutions in healthcare, education, and climate. Their investment in Medikabazaar indicates a focus on scalable healthcare enterprises with a potential for social impact.
What's next for Medikabazaar?
With substantial backing and a recent strategic investment, Medikabazaar is poised for accelerated growth. The company's focus on expanding its service offerings beyond product procurement suggests a strategy to deepen its integration within the healthcare ecosystem. Future initiatives likely involve enhancing its digital platform, optimizing logistics for wider reach, and potentially exploring new service verticals within the medical supply chain. The enterprise-level capital indicates a phase of significant scaling, aiming to solidify its leadership position in the Indian market and potentially explore international expansion opportunities. Continued investment in technology and customer support will be crucial for sustaining its competitive advantage.
See full Medikabazaar company page
